Cat.No. | Name | Information |
---|---|---|
M14821 | Prolylleucine | Prolylleucine is a dipeptide containing branched-chain amino acids. Prolylleucine can affect the circadian rhythms and behaviour of animals. |
M14819 | NEP(1-40) | NEP(1-40) is a Nogo-66 receptor (NgR) antagonist peptide, reversing the injury-induced shift in distribution of microglia morphologies by limiting myelin-based inhibition. |
M14813 | GPRP acetate | GPRP acetate (Gly-Pro-Arg-Pro acetate) is a fibrin polymerization inhibitor that inhibits the interaction of fibrinogen with the platelet membrane glycoprotein IIb/IIIa complex (GPIIb/IIIa). |
M14809 | CEP dipeptide 1 | CEP dipeptide 1 is a CEP dipeptide with potent angiogenic activity; mediators of age-related macular degeneration (AMD). |
M14808 | (Arg)9 TFA | (Arg)9 TFA (Nona-L-arginine TFA), a cell-penetrating peptide, exhibits neuroprotective activity with an IC50 of 0.78 μM in the glutamic acid model. |
M14804 | Acetyl-PHF6 amide TFA | Acetyl-PHF6 amide TFA (AcPHF6 TFA) is a tau derived hexapeptide. |
M14065 | Pasireotide L-aspartate salt | Pasireotide (SOM230) L-aspartate salt, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). |
M14064 | Pasireotide ditrifluoroacetate | Pasireotide (SOM230) ditrifluoroacetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). |
M13983 | Abarelix Acetate | Abarelix Acetate (PPI 149 Acetate; R 3827 Acetate) is a potent gonadotrophin-releasing hormone (GnRH) antagonist, used for prostate cancer research. |
M13972 | Semaglutide TFA | Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment. |
M13487 | Enfuvirtide acetate | Enfuvirtide (T20; DP178) acetate is an anti-HIV-1 fusion inhibitor peptide. |
M10881 | Ristocetin | Ristocetin is a peptide antibiotic that acts on the bacterial cell wall and inhibits the synthesis of the cell wall. The antimicrobial spectrum of risethibin is similar to that of vancomycin. Ristocetin has significant antibacterial activity against gram-positive bacteria, and has strong activity against hemolytic streptococcus, pneumococcus, Staphylococcus vanidavia, aerogenes and tetanus bacillus. |
M10870 | Orismilast | Orismilast (LEO-32731) is an orally active phosphodiesterase 4 (PDE4) inhibitor for use in inflammatory diseases and studies related to plaque psoriasis. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.